GSS vs OCC

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

GSS

GENETICSIG FPO [GSS]

45LOW

OCC

ORTHOCELL FPO [OCC]

45LOW

Score Breakdown

GSS OCC
Technical
73
50
Catalyst
53
51
Sentiment
50
50
Fundamental
66
83
Momentum
24
42
Risk Gate
50
45

Key Metrics

GSS Metric OCC
$18.2MMarket Cap$202.1M
562KAvg Volume (20d)408K
N/AShort Interest+0.5%
$0.69052-Week High$1.700
$0.07052-Week Low$0.725
+5.3%Daily Change+5.5%
$0.080Entry Price$0.765
-22.8%ROE-41.1%
-56.5%Profit Margin-133.8%

Active Signals

GSS Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (12 quarters)

OCC Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (15 quarters)
●Strong revenue growth (+49%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (2% of range)
●Deeply negative margins (-134%)

Ask Scout AI to compare GSS and OCC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
GSS Full Analysis → OCC Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).